HMGB1 and autoimmune hepatitis: The purpose of our study was to determine whether ethyl pyruvate could inhibit the expression and release of both early (TNF-α, IL-2, IL-6, IL-1β) and late (HMGB1 ) cytokines in Con A-induced autoimmune hepatitis.